Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
GoodRx Holdings, Inc. is a U.S.-based digital healthcare company operating at the intersection of healthcare technology, pharmaceutical pricing, and consumer health information. The company provides tools that allow consumers to compare prescription drug prices, access discounts, and find affordable care options. Its core mission is to increase transparency and affordability in the U.S. healthcare system, particularly within the prescription drug market.
The company primarily generates revenue through prescription transaction fees paid by pharmacy benefit managers (PBMs) and other partners when consumers use GoodRx discounts at pharmacies, as well as through subscription services and pharmaceutical manufacturer solutions. GoodRx Holdings, Inc. was founded in 2011 and gained widespread adoption through its free price comparison platform. The company went public in September 2020 and has since expanded beyond discounts into telehealth, medication adherence tools, and healthcare professional engagement.
Business Operations
GoodRx Holdings, Inc. operates through several core business segments, including Prescription Transactions, Subscription Services, and Pharmaceutical Manufacturer Solutions. The prescription transaction segment represents the largest revenue driver and is facilitated through contracts with PBMs and retail pharmacies, enabling consumers to access discounted drug prices. Subscription offerings, including GoodRx Gold, provide members with enhanced pricing and additional benefits for a recurring fee.
The company’s technology platform aggregates real-time pricing data from pharmacies nationwide and distributes it through its website and mobile applications. GoodRx Care, its telehealth offering, provides virtual consultations for common conditions, while manufacturer solutions include sponsored content and pricing programs aimed at improving drug access and adherence. Operations are primarily domestic, with the vast majority of revenue generated in the United States.
Strategic Position & Investments
Strategically, GoodRx Holdings, Inc. focuses on deepening consumer engagement across the medication lifecycle, expanding beyond one-time discounts toward recurring relationships. Growth initiatives have emphasized subscription expansion, telehealth integration, and data-driven tools for healthcare stakeholders. The company has pursued selective acquisitions to support these goals, including HeyDoctor, which formed the foundation of GoodRx Care.
The company continues to invest in platform enhancements, data analytics, and partnerships with pharmacies, PBMs, and pharmaceutical manufacturers. Emerging areas of focus include medication affordability programs, chronic condition management tools, and expanded healthcare content aimed at both consumers and healthcare professionals. While competitive pressures exist, GoodRx maintains a differentiated position through brand recognition and scale in prescription price comparison.
Geographic Footprint
GoodRx Holdings, Inc. is headquartered in the United States, with its principal executive offices in California. Its operations and customer base are overwhelmingly concentrated in the U.S. market, reflecting the country’s complex and fragmented prescription drug pricing environment.
Although the company does not have significant international operations, its platform reaches consumers nationwide through partnerships with tens of thousands of retail pharmacies across all U.S. states and territories. International expansion has not been identified as a near-term strategic priority based on publicly available disclosures.
Leadership & Governance
GoodRx Holdings, Inc. is led by a management team with experience in technology, healthcare, and consumer internet businesses. The leadership emphasizes data-driven decision-making, consumer empowerment, and collaboration with healthcare system participants to improve affordability and access.
Key executives include:
- Douglas Hirsch – Co-Chief Executive Officer
- Trevor Bezdek – Co-Chief Executive Officer
- Scott Wagner – President
- Brian Peterson – Chief Financial Officer
- Dorothy Gemmell – Chief Legal Officer and Secretary
The company operates under a board-led governance structure consistent with U.S. public company standards, with oversight of strategy, risk management, and executive compensation guided by applicable regulatory and fiduciary frameworks.